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Heterocyclic compoundsAbstract This review article describes the survey of literature regarding the variety of synthetic
methods of 1,3,4-thiadiazoline and related compounds in the last seven years (2004–2010). The
aim of the review is to ﬁnd out different methods for the synthesis of thiadiazolines. These hetero-
cyclics are majorly obtained from the cyclization reactions of thiosemicarbazone under the various
conditions. From the literature studies it was found that major importance was given to their phar-
maceutical signiﬁcance i.e., regarding their biological activity against different fungal and bacterial
strains.
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Heterocyclic chemistry is an integral part of the chemical sci-
ences and constitutes a considerable part of the modern
researches that are occurring presently throughout the world.
The chemistry of heterocyclic compounds is as logical as the
chemistry of aliphatic or aromatic compounds. The study of
heterocyclic systems is of great interest both from the theoret-
ical and practical point of view. Heterocycles also play an
important role in the design and discovery of new physiologi-
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526 M. Yusuf, P. Jaincal/pharmacologically active compounds. Five membered
aromatic systems having three heteroatoms at the symmetrical
positions have been studied because of their interesting physi-
ological properties (Hetzhein and Mockel, 1996). In the recent
decades, the synthesis of substituted thiadiazolines (Wilkins,
2008; Shih and Wu, 2005; Ogurtsov et al., 2005) and related
compounds has attracted considerable attention because
these compounds constitute the structural frameworks of12a-c
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Schemeseveral naturally occurring alkanoids that show a wide range
of pharmaceutical and industrial importance (Kornis, 1996).
The technological uses of these compounds include dyes,
optically active liquid crystals and photographic materials.
Thiadiazolines, thiadiazoles and oxadiazolines possess a wide
range of biological properties and they act as anthelmintics
(Chen and Xiao, 2004; Xiong et al., 2002; Wang et al.,
2003), antihypertensive (Oh et al., 2002), antitumour (Ilies
et al., 2003; Masereel et al., 2002; Supuran and Scozzafava,
2000), analgesic, anticancer, anti-inﬂammatory and anti-
bacterial (Amir and Shikha, 2004; Demirbas et al., 2004;
Palaska et al., 2002; Holla et al., 2002; Awad and El Ashry,
1998), tyrosinase inhibitory activity (Khan et al., 2005). The
macrocycles containing thiadiazoline and thiadiazole
subunits are found to be interesting host guest complexation
characteristics (Bradshaw et al., 1990) and also exhibit
antibacterial activities (Collier et al., 2000; Elizabeth et al.,
2003; Jian et al., 2008; Huang et al., 2002). Some synthetic
routes for the synthesis of 1,2,3-thiadiazolines had been
reported in literature (Vasiliy and Wim, 2004).
2. Discussion
The compounds 8 bearing two symmetrical 1,2,5-thiadiazole
(Philipp et al., 2004) ligands had been synthesized (Scheme 1)
in order to investigate the co-ordination catalyst for the co-N
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vinyl acetate) with ethylene. Here major investigations had
been carried out on the complexes of transition metals with
heterocyclic ligands 8.
The reaction of 3-benzoyl-5-perﬂuoroalkyl-1,2,4-oxadiaz-
oles 12a–c with hydrazine had been initiated via the electro-NH2 C OC2H5
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(Buscemi et al., 2005), followed by ring opening and ring
closure with enlargement to yield Z-oximes of 3-
perﬂuoroalkyl-6-phenyl-2H-1,2,4-triazin-5-ones 17a–c as the
major products of reaction under the mild experimental
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528 M. Yusuf, P. Jainattack upon the carbonyl carbon giving 4-perﬂouro-
acylamino-5-phenyl-2H-1,2,3-triazoles 16a–c through the
well-known Boulton–Katritzky rearrangement of the
intermediate hydrazones (Schemes 3 and 4). Five memberedRCOCH3 RCOCH2Br
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The researches are also carried out on the synthesis and bio-
logical activities of thiosemicarbazone 20 and thiadiazolinesRCOCH2S
+(CH3)2Br
-
O
N
N
H
R
Ar
+
S(CH3)2
:NNHAr
X
N
N
Ar
NNO
X
N
N
Ar
O
C
O
55
ArN(NO)COCH3
56
 C6H5
-CH3C6H4
60
61
58-63a =  Ar= 4-CH3C6H4, X=S
58-63b =  Ar= 4-CH3C6H4, X=Se
Br-
8
Synthesis and biological signiﬁcances of 1,3,4-thiadiazolines and related heterocyclic compounds 529(Brousse et al., 2004) 21 (Scheme 5). It had been observed that
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showed activity against the large numbers of bacteria than
the aromatic derivatives 22–28.
Amir et al. (2004) have studied the synthesis and
antibacterial/anti-inﬂammatory examinations of new trizoles
39a–b, thiadiazoles 40a–b, oxadiazoles 41a–b and 4-thiazolidi-
none derivatives 42a–b (Scheme 6). It was observed that in
oxadiazole derivatives, the maximum activity (72.34%) was
shown by compound 45a having a a-methyl-4-isobutyl benzyl
group at position 2 but the replacement of this group by a sim-
ple phenyl group lead to a sharp decrease in the activity
(22.34%). When phenyl group is replaced by mercapto group
as in 43, 20-hydroxy phenyl group as in 45d and 20-acetoxyphe-nyl group as in 45e then activity was found to be increased.
When these groups are further replaced by 2,4-dichlorophenyl
as in 45c and amino groups as in 44 the activity was found to
be decreased. On the basis of these results it was concluded
that alkyl substituted phenyl rings were more preferable for
the anti-inﬂammatory behaviours.
The reaction (Holla et al., 2004) of 2-chloropyridine-5-acetic
hydrazide 49 with aroyl isothiocyanates 48a–e yielded 4-
aroyl-1-(2-chloropyridine-5-acetyl)thiosemicarbazides 50a–e.
The cyclization of later with conc. sulfuric acid and I2 + KI
afforded 2-chloro-5-(5-aroylamino-1,3,4-thidiazol-2-yl-methyl)-
pyridines 51a–e and 2-chloro-5-(5-aroylamino-1,3,4-oxadiazol-
2-yl-methyl)pyridines 52a–e, respectively as the ﬁnal
heterocyclic products (Scheme 7).
Some of new compounds like thiadiazolines 69 and 70,
seleniumdiazolines 60b–63b and triazolino[4,3-a]pyrimidines
73 (Abdelhamid et al., 2004) have been obtained in the
past starting from 3-aza-[2,4-dimethyl(1,3-thiazol-5-yl)-
2-bromo-3-substituted-amino]prop-2-en-1-one under the
reaction condition as shown in Schemes 8–12.
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532 M. Yusuf, P. JainShih and Wu (2005) have studied the reaction of thiosemi-
carbazones 89a–d with acetic anhydride 90a in the presence
of ferric chloride to give 4-acetyl-2-phenylamino-5-(3-
arylsydnon-4-yl)-4,5-dihydro-[1,3,4]thiadiazoles 91a–d and 4-
acetyl-2-(N-phenylacetamido)-5-(3-arylsydnon-4-yl)-4,5-dihy-
dro[1,3,4]thiadiazoles 92a–d (Scheme 13). However under
similar conditions thiosemicarbazones 89e–h producedBr
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O S
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Scheme 2only 4-acetyl-2-acetamido-5-(3-arylsydnon-4-yl) 4,5-dihydro-
[1,3,4]thiadiazoles 92e–h in high yield (Scheme 14). The
sydnonyl-substituted thiadiazole derivatives 93a–h were also
prepared successfully by the cyclization of 3-aryl-4-
formylsydnone thiosemicarbazone 89a–h in the presence of
ferric chloride (Scheme 15). The cyclization reaction of
thiosemicarbazones 89a–d could occur easily than
thiosemicarbazones 89e–h.
Ogurtsov et al. (2005) prepared 1,3,4-thiadiazolines 97 of
1,2-dithiole-3-thiones (Schemes 16–18). The thiocarbonyl
group of 4,5-dichloro-1,2-dithiole-3-thione reacts as a
dipolarophile towards dicarbonyl nitrile imines by 1,3-
dipolar cycloaddition followed by opening of the dithiole
ring with loss of sulfur to give 5-methylene-1,3,4-
thiadiazolines. This reaction together with nucleophilic
displacement of the selectively reactive 5-chloro group
provides a rapid access to stable 5-methylene-1,3,4-
thiadiazolines. Here compound 97aa was obtained by 1,3-
dipolar cycloaddition followed by the loss of sulfur, but it
was too unstable to be isolated. The reaction of 95a and 94a
with triethylamine in benzene solvent at room temperature
followed by addition of phenol or thiophenol led to the
formation of thiadiazolines 97ab and 97bc, (X = O and S) in
low yields.
The reactions (Caram et al., 2006) of n-butylamine, 2-
aminoethanol, diethylamine and phenylhydrazine with 98a
were studied by cyclic voltammetry. The course of the
reactions was dependent on the nucleophile-substrate
combination: Et2NH added to 98a, forming the[RCOC-N=NAr]..
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534 M. Yusuf, P. Jaincorresponding thiadiazolines in an equilibrium mono addition
reaction. The equilibrium constants were evaluated and
compared. With primary amines and PhN2H3, the
nucleophile added to both C‚N double bonds of 98a and
displayed the sulfamide moiety. BuNH2 and H2N(CH2)2OH
reacted with 98a to give bis-imines, while 98a with PhN2H3
gave the a-bis-hydrazone (Scheme 19). The conﬁguration of
benzil-bis(ethanolamine) and benzilosazone were determined
by single X-ray diffraction analysis as Z, Z.
The synthesis of new 1,3,4-thiadiazole (Schenone et al.,
2006) 102 derivatives endowed with analgesic and anti-
inﬂammatory activities have been reported. Two series of N-
[5-oxo-4-(arylsulfonyl)-4,5-dihydro-1,3,4-thiadiazol-2-yl]-amides
102a–t (Scheme 20) were synthesized and tested in vivo for
their analgesic and anti-inﬂammatory activities. All the new
compounds were found to exhibit good analgesic action
and some compounds also showed fair anti-inﬂammatory
activity in the carrageenan rat paw oedema test. Ulcerogenic
and irritative action on the gastrointestinal mucose, in
comparison with indomethacin was observed to be low.
Zaki et al. (2006) have prepared 2,3-dihydro-1,3,4-thia-
diazoles 112–115 and 120, in good yields from the reactions
of hydrazonoyl halides with alkyl carbodithioates,
pyrimidine-2-thione and substituted prop-2-ene-1-one,
respectively (Schemes 21–23). Some of these compounds
were also tested against the bacteria and fungi strains.
Mazoir et al. (2006) synthesized some steroidal based
spirocyclic thiadiazolines under the ordinary conditions as
shown in Scheme 24.
The heterocyclic derivatives (Mithun and Holla, 2007) 7-
(substituted aryl/aryloxy methyl-3-(4-methylthiobenzyl)-4H-
1,3,4-thiadiazolo [2,3-c]-1,2,4-triazin-4-ones 130a–d andR S NH Z
NH NH
O SH
O
O
NH2 Z COOH
R S Cl
O
O
1
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CH3 *CH
CH2
CH3
CH3 CH3 *CH
CH2
CH3
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CH2
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CH3
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CH3
c) Z= 2g)      Z=                , R=CH3 h) R= Cl, i) R
CH3 *CH
CH3
CH3 CH3 *CH
CH3
CH3d) Z= 2j) Z=                           , R=CH3 k) R= Cl, l) R
1) aq. 5% NaOH, ether, 230C, 6h; 2) H2SO4/EtOH, reflux; 3) N
Scheme 2131a–d were prepared by reacting 4-amino-6-(4-methylthio-
benzyl)-3-mercapto-1,2,4-triazin-5(4H)-one 129 with substit-
uted benzoic acids/aryloxy acetic acids in the presence of
phosphorus oxychloride. 4-Amino-6-(4-methylthiobenzyl)-
3-mercapto-1,2,4-triazin-5(4H)-one 129 was prepared by
reacting 4-(4-methylthiobenzylidene)-2-methyl-oxazol-5-
one(3) with thiocarbohydrazide 128 by reﬂuxing in aq. EtOH
(Scheme 25). The antibacterial and antifungal activities were
carried out for 130a–d and 131a–d and all the tested
compounds were possessing moderate activity for both
microbes.
The treatment of 132 with carbon disulﬁde in the presence
of potassium hydroxide resulted in the formation of 1,3,4-thia-
diazole (Mahmoud et al., 2007) 135 (Scheme 26).
The literature (Zareef et al., 2007) also describes the
synthesis of a series of novel chiral and achiral N-[1-(1,3,4-
oxadiazol-2ylthiol alkyl]-4-methyl/chloro/methoxy benzenes-
ulfonamides 140a–l (Schemes 27 and 28). These compounds
were prepared by the reaction of 4-[4-methyl, chloro,
methoxyphenylsulfonamido) alkyl carboxylic acid hydrazides
139a–l with CS2 and KOH. Another series of new secondary
benzenesulfonamides 145a–j and bis-benzenesulfonamides
146a–j have also been synthesized by a new approach using
Et3N and dimethylaminopyridine. The compounds 136a–d
were converted into their corresponding sulfonamides 137a–l.
Esteriﬁcation of 137a–l with ethanol in an acidic medium
afforded esters 138a–d and reaction of later with 80%
hydrazine hydrate furnished hydrazides 139a–l in good
yields. The products 140a–l were then prepared by the
reaction of hydrazides 139a–l. The hydrazides 141a–e were
converted into 142a–e by treatment with 4-nitrobenzo-
ylchloride in dry MeCN. Compounds 142a–e were subjectedR S NH Z C
O
O
NH NH2
O
R S NH Z C
O
O
OC2H5
O
R S NH Z COOH
O
O
2
3
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give 143a–e. The reduction of 143a–e with Pd/C and hydrazine
hydrate produced 144a–e in good yields. The treatment of
144a–e with Et3N and dimethylaminopyridine furnished the
sulfonamides 145a–e and 146a–e (Scheme 28). The prepared
compounds were also checked for their anti-HIV activity.
Twenty one new thiophene substituted 1,2,4-oxadiazol-
5(4H)-ones (Durust et al., 2007) 152a–g, 1,2,4-oxadiazol-C NH NH2
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536 M. Yusuf, P. Jain5(4H)-thiones 154a–g and 1,2,4-oxadiazin-5(6H)-ones 160a–g
were synthesized by the reaction of thiophene ring substituted
amidoximes with ethyl chloroformate, thiophosgene and chlo-
roacetylchlorine, respectively according to the protocol as
described in Schemes 29–32.
Ying et al. (2007) have investigated the synthesis of a series
of ﬂavanoid based thiadiazoline 170 and 171. These
heterocycles were synthesized by the cyclization of theOH
CH3
O
+ OHC
R'1
R'2
OH
OR'1
R3 NHNH2 +
O
HNNR'1
R'1
O
S
N N
Cl
161 162 163
165
162
166 R3 =NO2
167 R3= SO2Me
168 R3 =NO2
169  R3= SO2Me
EtOH, HOAc
reflux, 6 h
KOH/ EtOH
r.t. 24 h
Scheme 3corresponding 2-arylchroman-4-one-arylhydrazones 166 and
167 with SOCl2 followed by treatment with alcohol (Schemes
33 and 34). The resulting compounds 170 and 171 were also
examined for their antiproliferative activity in vitro against
six human tumour cell lines and the derivative 171a was
found to have higher inhibitory effect upon the growth of
tumour cell.
The spirocyclic oxadiazole (Islam and Mohsin, 2007) 179
were synthesized successfully starting from p-chloroaniline
through the sequence of reactions as shown in Scheme 35.
The cyclization (Li et al., 2007) reactions of 3-aryl-4-amino-
5-mercapto-1,2,4-triazoles 181a–o with hexanedioic acid in the
presence of POCl3 and Bu4N
+I as a catalyst provided 1,4-
bis(3-aryl)-1,2,4-triazolo[3,4-b]–[1,3,4]thiadiazole-6-yl]butanes
182a–o (Scheme 36). The compounds 182a–o were screened for
their anti-bacterial and compounds 182d, 182n and 182o
showed better antibacterial activity.
The inhibition activity on carbonic anhydrase I of some
substituted thiadiazole and thiadiazoline-disulfonamides
(Bolboala, and Jantschi, 2007) have been studied. The
structure activity relationships based upon an original
molecular descriptors family method has been developed and
applied on a sample of substituted 1,3,4-thiadiazole and
1,3,4-thiadiazoline-disulfonamides. Forty compounds were
studied for their inhibition activity on carbonic anhydrase I.
The results revealed that the molecular descriptions family
on structure activity relationships is a useful approach in the
characterization of inhibition activity on carbonic anhydrase
I of studied substituted 1,3,4-thiadiazole and 1,3,4-
thiadiazoline-disulfonamides.
In order to investigate a better antimicrobial agent, 1,3,4-
thiadiazoles (Banday and Rauf, 2008) 186a–d bearing long
alkenyl and hydroxyl-alkenyl chain have been synthesizedR'2
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Synthesis and biological signiﬁcances of 1,3,4-thiadiazolines and related heterocyclic compounds 537(Scheme 37) and their antibacterial activity has also been
examined.
Abdelhamid et al. (2008) have prepared 1,3,4-thiadiazolines
containing a chromone moiety and 5-{1-[4-substituted-5-phen-
yldiazenyl)(1,3-thiazol-2-yl]-5-phenyl-2-pyrazoline-3-yl)}-4-
methoxybenzo[b]-furan-6-ol. These compounds were prepared
from the reaction of hydrazonoyl halide and alkyl carbodithio-C N C S
O
R C NH NH2
O
C
O
184a-d
184a-186a      CH2=CH(CH2)8   , 184b-186b  CH3(CH2)7CH=CH(CH2)7
184c-186c    CH3(CH2)5CH(OH)CH2CH=CH(CH2)7   , 184d-186d  CH3(C
183
Scheme 3ates and 5-[1-aminothiomethoxy)-5-phenyl-2-pyrazolin-3-yl)]-
4-methoxybenzo[b]-furan-6-ol, respectively (Schemes 38–41).
Er et al. (2008) have investigated the cyclization reactions
of new tetra-thiosemicarbazone. The tetra-aldehyde and
ketone derivatives 205a–d which were used in these syntheses
were obtained via the reaction of ethane-1,1,2,2,tetra-yl-tetra-
methylene-tetra-bromide with aldehydes and ketones. TheNH C NH NH C R
O
S
C NH
O NN
S
R
185a-d
Conc. H2SO4
186a-d
H2)4CH=CH(CH2)2CH(OH)(CH2)7
7
538 M. Yusuf, P. Jainreactions of tetra-aldehydes and ketone derivatives 205a–d
with thiosemicarbazite and 4-methyl thiosemicarbazite led
to the formation of 206a–h. In the same way, tetra-4-methyl-O
OMe
CH3
OH
O
+ H2NNHC(S)SR
R'C(X):NNHC6H5 + 189
190
+
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Scheme 45-ethoxycarbonyl 1-2,3-dihydro-1,3-thiazoles 207a–h were
synthesized via the reaction of tetra-thiosemicarbazone
compounds 206a–h with ethyl-2-chloroacetoacetate. FinallyO
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Synthesis and biological signiﬁcances of 1,3,4-thiadiazolines and related heterocyclic compounds 539compounds 206a–h were reacted with acetic-anhydride under
reﬂuxing to yield tetra-2-acetyl-amino-4-acetyl-4,5-dihydro-
1,3,4-thiodiazol compounds 207a–d and 208a–d (Scheme 42).
The interaction of a,b-unsaturated ketones of furan series
(Anis’Kov et al., 2009) with thiosemicarbazide under basic
catalysis condition led to 3-furyl-2-thio-carbamoylpyrazolines
and the intramolecular cyclization of thiosemicarbazones
under conditions of acid activation of sulfurous nucleophile
provided spirocyclic furylmethylene 1,3,4-thiadiazoline. These
heterocycles are of potential biological activity and can be
used in medicines.
The heterocyclization of 210a–d under the acylation condi-
tion proceeded regioselectively to give 5-furfurylidene-1,
3,4-thiadiazoline including spirocyclic one. The use of basic
catalysis in these reactions allows one to carry out region direc-
ted synthesis of N-thiocarbamoyl pyrazolines (Scheme 43).
A series of novel 2-(1-substituted-1,11-undecylidene)-5-aryl-
imino-D-1,3,4 thiadiazolins (Jin et al., 2009) 218 had been
synthesized and their solubility in polar and non polar
solvents was signiﬁcantly improved owing to the introduction
of ethyl or methylthio group at cyclodecyl ring as compared
with parent compounds [1,2-(1,11-undecylidene)-5-aryl
imines-D-1,3,4-thiadiazolines] (Scheme 44). However their
fungicidal activity against Rhizoctonia Solanu is less than
that of parent compounds.
The [3+2] cycloaddition reaction (Jayashankar et al., 2009)
of nitrile oxide with allyl alcohol followed by intramolecular
1,3-dipolar cycloaddition reaction of nitrile imine with
carbonyl group could led to the formation of novel ether
linked bis(heterocycles) (Scheme 45). These bisheterocycles
were also tested for anti-inﬂammatory and analgesic
activities and 225g exhibited highest activity among the
tested products 225a–e.
The reaction of trans-1,4-dichloro-2-butene 226 with phe-
nol afforded (E)-1,4-bis(aryloxy)-2-butene Er et al., 2009
228a–d which were converted into bis-thiosemicarbazones
229a–h by reacting with thiosemicarbazide and 4-methyl
thiosemicarbazide, respectively. Similarly, 4-methyl-5-
ethoxycarbonyl-2,3-dihydro-1,3-thiazoles 231a–h were
synthesized via the reaction of bis-thiosemicarbazones 229a–
h with ethyl 2-chloroacetoacetate. trans-1,4-Dithiocyanato-2-
butene 230 was obtained from the reaction of KSCN and
trans-1,4-dichoro-2-butene 226. Furthermore, the bis-2-
amino-1,3,4-thiadiazoles 232k and I were realized from the
reaction of trans-1,4-dithiocyanato-2-butene 230 with
thiosemicarbazide and 4-methyl thiosemicarbazide,CHO
OMe
OMe
+ H2NNHC:(S)SR
202
188
a, R'= COC2H5; b, R'= COCH3; c, R'=COC6H5
188, 203a, R= CH3, b, R=CH2C6H5
Scheme 4respectively (Scheme 46). Finally the microbial activities of
all the compounds 231a–h were also determined.
The synthesis of some new heterocyclic compounds
(Pawar et al., 2009) has been reported containing spiro-
benzopyrans, thiadiazoles, selenadiazoles and thiadiazolines
as the subunits (Scheme 47). The anti-microbial and
anti-fungal analyses of the heterocycles have been carried
out.
The condensation reaction of 4-amino-5-(aroyl)-4H-1,2,4-
triazole-3-thiols 240a–b or 2-amino-5-mercapto-1,3,4-thiadia-
zole with bis-aldehydes 239a–c provided bis-schiff bases
241a–d and 245a–c (Foroughifar et al., 2009) which were
further treated with dibromoalkanes to afford the new
macrocycles 243a–f and 247a–d, respectively (Schemes 48
and 49).
Recently, multistep synthesis of the steroidal based
thiadiazolone derivatives (Khan and Yusuf, 2009) has been
reported. The target compounds 254–256 were obtained from
the cyclization of thiosemicarbazones 251–253 with
bromoethylacetate in dioxane medium. The later were
prepared from the reaction of steroidal ketones 248c–250c
with thiosemicarbazones (Scheme 50). The antibacterial
analysis of the compounds 254–256 showed that steroidal
thiozolidinone derivatives are better in inhibiting the growth
as compared to steroidal thiosemicarbazones.
El-Sayed et al. (2009) have investigated the synthesis of a
series of new disubstituted 2,5-thiazolidinone derivatives
260a–d, 262a–d and 264a–d (Scheme 51). The antimicrobial
examination of these compounds has also been carried out
against gram positive and gram negative bacteria strains and
actinomycetes.
The 1,3,4-thiadiazoline ( Umamatheswari and Kabilan,
2009) 267 had been obtained starting from 3-methyl-2,6-
diphenyltetrahydrpopyran-4-one 265 which was treated with
thiosemicarbazide to give 266. The cyclization later with
Ac2O resulted in the formation of ﬁnal product (Scheme 52).
These results showed that the title compounds exist in chair
conformation with equatorial orientations of phenyl group at
C-2, C-6 methyl group at C-3 carbons and N-acetyl group of
thiadiazoline moiety.
Some halogenated thiadiazoles and trizoles (Radhavane
et al., 2010) were synthesized initially starting from acid
hydrazine 268 under the conventional and ultra sound
irradiation method (Scheme 53). These heterocyclic
compounds 270 and 271 were also examined for their anti-
microbial, antiviral and anti-oxidant activities.N
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540 M. Yusuf, P. JainA reaction of alkenoic acid hydrazides 272a–d with phenyl-
isocyanate and phenylthiocyanate yielded semicarbazides
273a–d and thiosemicabazide (Farshori et al., 2010) 275a–d,
respectively, which were further reﬂuxed with POCl3 and
Ac2O to provide 1,3,4-oxadiazoles 274a–d and thiadiazoles
276a–d, respectively (Schemes 54 and 55). The anti-bacterialand anti-fungal analyses of the synthesized compounds have
also been carried out.
A series of new 2-imino-5-[(Z)-1-(4-methylphenyl)methy-
lidene]-3-[5-(2-oxo-2H-3-chromenyl)-1,3-oxazol-2-yl]-1,3-thia-
zolan-4-ones (Reddy et al., 2010) 281a–j have been synthesized
(Scheme 56) and assayed for their antibacterial activity.
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Synthesis and biological signiﬁcances of 1,3,4-thiadiazolines and related heterocyclic compounds 543Among the screened products, the compounds 281d, 281e,
281f, 281g and 281j exhibited better activity as compared to
the standard drug and emerged as potential derivatives for
further researches.
Kabilan and co-workers have investigated the synthesis of
some novel 2,4-[diaryl-3-azabicyclo[3.3.1]nonan-9-yl]-5-spiro-
4-acetyl-2-(acetylamino)-D-1,3,4-thiadiazolines (Rani et al.,
2010) derivatives 285a–h. These compounds were obtainedby the cyclization of 2,4-[diaryl-3-azabicyclo[3.3.1]nonan-
9-one thiosemicarbazones 284a–h under acetic anhydride
medium (Scheme 57).
The macrocyclic compounds containing heterocyclic sub-
units have attracted the attention of synthetic chemists as
these molecules can act as ligand in the asymmetric cataly-
sis (Cho et al., 2010) and as a host molecule for the
incorporation of metal ions. Nam Sook Cho and et al
Cholesterol
248a
249a 250a
CH3
CH3
CH3
CH3
NO2
CH3COO
CH3 CH3
CH3
CH3
CH3
NO2
Cl
CH3
CH3
CH3
CH3
CH3
NO 2
CH3
CH3
CH3
CH3
CH3
O
CH3COO
CH3 CH3
CH3
CH3
CH3
O
Cl
CH3 CH3
CH3
CH3
CH3
O
CH3
CH3
CH3
CH3
CH3
CH3COO
CH3
N NH
S
NH
CH3
CH3
CH3
CH3
Cl
CH3
N NH
S
NH
CH3
CH3
CH3
CH3
CH3
N NH
S
NH
NH2 NH
S
NH
NH2 NH
S
NH
NH2 NH
S
NH
CH3
CH3
CH3
CH3
CH3COO
CH3
N N
S
N
O
R
CH3
CH3
CH3
CH3
Cl
CH3
N N
S
N
O
R
CH3
CH3
CH3
CH3
CH3
N N
S
N
O
R
R=
254 255 256
Br
O
O CH3Br
O
O CH3 Br
O
O CH3dioxanedioxane dioxane
acetic acid
acetic acid acetic acid
Zn dust
Zn dust Zn dust
Fuming HNO3 Fuming HNO3
Fuming HNO3
acetic anhydride/ pyridine thionyl chloride
248b
249b 250b
248c
249c
250c
251 252 253
1a= 3   aetoxycholest-5-ene 2b)3β chlorocholest-5-ene 3a) cholest-5-eneβ
Scheme 50
544 M. Yusuf, P. Jainhave developed the synthesis of novel macrocycles 289a–f
containing 2-imino-5-mercapto-3H-1,3,4-thiadiazoline unit
linked at 3 and 5 positions through the ethyl, butyl andm-xylene moiety (Scheme 58). The X-ray diffraction
studies could become helpful to ascertain the structure of
these compounds.
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546 M. Yusuf, P. JainThe signiﬁcant biological properties (Hossain et al., 2010)
(like anti-oxidant, anti-microbial and anti-cancer) associatedto the Isatins has promoted the synthesis and biological
evaluation of the new heterocyclic compounds 293a–c, 294d–
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Synthesis and biological signiﬁcances of 1,3,4-thiadiazolines and related heterocyclic compounds 547f and 296g–j. These compounds were obtained by the synthetic
routes as shown in Scheme 59.
Heng-Shan Dong et al. have synthesized N-[4-acetyl-
4,5dihydro-5-(1-aryl-5-methyl-1H-1,2,3-triazol-4-yl)-5-methyl-
1,3,4-thiadiazol-2-yl]acetamide (Wang et al., 2010) derivatives
299a–j according to the protocol as described in Scheme 60.
Recently, new acridone based 1,3,4-oxadiazoles (Salimon
et al., 2010) 305 have been obtained starting from the
reaction of 2-chlorobenzoic acid with 4-aminobenzoic acid
(Scheme 61). These compounds are also associated with the
signiﬁcant anti-bacterial and anti-fungal activities.A novel series of pyridyl substituted oxadiazole (Shirote
and Bhatia, 2011) 309a–f have been synthesized through the
cyclization of carbonyl hydrazone under the excess of acetic
anhydride and subsequent condensation with various
aromatic amines (Scheme 62). These compounds were also
screened for their goat pulmonary vein relaxant activity and
compound PSMB9 was found to be the most active
derivative exhibiting 83.33% relaxation.
Recently, synthesis and anti-microbial analysis of some new
1,2,4-thiadiazolinediones (Alagawadi and Alegaon, 2011)
314a–g and 318a–g (Schemes 63 and 64) have been reported
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Synthesis and biological signiﬁcances of 1,3,4-thiadiazolines and related heterocyclic compounds 549by Shankar G. Alegaon and co-workers. These heterocycles
exhibited high to moderate biological behaviour against the
tested bacteria and fungi strains.Recently, synthesis of new heterocyclic compounds
(Duan et al., 2010) 322a–f has been carried out through
the multi step reactions as shown in Scheme 65. The
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550 M. Yusuf, P. Jainherbicidal activities of these compounds have also been
examined against a variety of weeds. This study showed
that most of the synthesized compounds had moderate
inhibitory activities and selectivities against root and stalk
of monocotyledon and dicotyledon plants. The chiral
compounds showed improved herbicidal activities to some
extent over their racemic counterparts against a variety of
tested weeds.Cl NH
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S S
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Scheme 6The bisthiadiazolines (Yusuf and Jain, 2012) 325a–h built
around the alkyl chains of varying lengths have been
synthesized in good yields by reﬂuxing bisthiosemicarbazones
324a–h in acetic anhydride. The reactions of bisaldehydes
323a–h with thiosemicarbazide in alcoholic medium provided
324a–h. The formation and stereochemical features of the
bisthiadiazolines 325a–h were found to be independent of the
internal spacer length (Scheme 66).H2COOC2H5 Th
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Synthesis and biological signiﬁcances of 1,3,4-thiadiazolines and related heterocyclic compounds 5515-(4-Chlorophenyl amino)-2-mercapto-1,3,4-thiadiazole
(Sah et al., 2014) was reﬂuxed with formaldehyde and
ammonium chloride in ethanol to yield Mannich base 5-(4-
chloro phenyl amino)-3-aminomethyl-2-mercapto-1,3,
4-thiadiazole 326. Esteriﬁcation of later with 4-chloro-(2,6-
dinitrophenoxy)-ethyl acetate 327 under anhydrous
conditions gave the intermediate 328 which upon subsequent
hydrazinolysis with hydrazine hydrate gave the
corresponding hydrazide 3-amino methyl-5-(4-chloro phenyl
amino)-2-mercapto-40-(20,60-dinitro phenoxy)-acetyl hydrazide
329. The hydrazide was converted into the Schiff bases
330a–b by reacting with 2-chlorobenzaldehyde and 3-
methoxy-4-hydroxy-benzaldehyde in presence of methanol
containing 2–3 drops of acetic acid. The diazotization of
330a–b with aromatic amines, sulfanilic acid and sulfur drugs
gave the formazans 331a–g, respectively (Scheme 67).Acknowledgement
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